Why Broadcom Stock Dropped Today

Broadcom topped Q3 expectations with EPS of $3.32 on $29.6B sales (vs $3.21 on $29.2B), while free cash flow rose 34% to $13.7B. However, Q4 guidance implies a sales miss—Wall Street expected >$35B, while Broadcom’s outlook was about $34.8B, with AI accelerators driving revenue (AI projected to be 62% of Q4 sales and to triple again to $21.7B). The stock fell 6.3% by 10:30 a.m. ET, as investors focused on the guidance gap despite the earnings beat.

Analysis

The market is penalizing the gap between a still-hot AI revenue run rate and the much harder question of sequencing. In semis, the first derivative matters more than the absolute level: once investors start treating AI as a straight-line story, any quarter that implies digestion or lumpy bookings gets de-rated fast, even if the underlying demand is intact. That makes AVGO the cleaner short-term loser versus the broader AI basket, while NVDA can benefit on a relative basis if capital gets rotated toward the most liquid, highest-confidence AI platform name.

Second-order, this is less about demand destruction than about mix and timing. If hyperscalers are normalizing their custom silicon ramps, the risk is that networking and adjacent infrastructure names also see less smooth order flow over the next 1-3 months, which can pressure the whole SMH complex through estimate cuts rather than fundamentals. The contrarian takeaway is that the selloff may be overdone if investors are extrapolating a one-quarter guide into a structural slowdown; the longer arc still looks supportive as long as AI capex budgets remain elevated.

The key falsifier is not one bad print but a second consecutive miss in AI guidance or commentary that incremental spend is shifting to digestion rather than deployment. If that happens, AVGO’s multiple should compress further and sympathy weakness could spread to NVDA, ARM, and the rest of the AI infrastructure trade. Until then, the setup looks more like a valuation reset than a demand break.

Key Decisions for Investors

• Trade the relative value: long NVDA / short AVGO for 3-6 months, targeting continued multiple divergence if AVGO’s guidance remains the weaker read-through and NVDA’s earnings cadence stays cleaner.
• Do not add to AVGO immediately after the gap down; wait for either a further 5-7% washout or evidence of stabilization in the next hyperscaler capex commentary before buying.
• Use SMH as the cleaner vehicle for the AI complex: buy weakness only if semis stop extrapolating AVGO’s guide miss into sector-wide demand fears; stop if the ETF breaks the post-earnings low.
• Watch the next 1-3 month catalyst set: hyperscaler spending updates and any revision to AVGO’s AI revenue trajectory. If those soften, reduce AI beta exposure across NVDA/SMH.